Clinical Trial Update: Infracoccygeal Botox for Dyssynergia

View source ↗

Summary

A completed clinical trial evaluating infracoccygeal injections of Botox (onabotulinumtoxinA) for dyssynergic defaecation/evacuation disorders has posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anismus
• Defecation Disorder
• Dyssynergic Defaecation
• Evacuation Disorder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Queen Mary University of London | Conditions: Dyssynergic Defaecation, Evacuation Disorder | Status: COMPLETED | Results posted: 2025-03-21